Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
39,662,028
-
Share change
-
-4,474,584
-
Total reported value
-
$56,340,358
-
Put/Call ratio
-
9%
-
Price per share
-
$1.43
-
Number of holders
-
55
-
Value change
-
-$2,625,416
-
Number of buys
-
25
-
Number of sells
-
24
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q3 2017
As of 30 Sep 2017,
TRANSENTERIX INC - COM NEW (TRXC) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,662,028 shares.
The largest 10 holders included
Aisling Capital LLC, SV Health Investors, LLC, JPMORGAN CHASE & CO, MASTERS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, StepStone Group LP, CREDIT SUISSE AG/, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.